Thus, mitochondria- and NOX4-derived ROS function in concert to drive a NFE2L2 antioxidant defense response to attenuate oxidative liver damage and progression to NASH and fibrosis in obesity. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.